Syros Pharmaceuticals, Inc. Financial Ratios — SYRS Stock

Profitability (USD)

	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-56.73	-70.75	-63.61	-67.24	-58.77	-46.27	-43.7	-44.29	-79.76
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	100	100	100	100	100	100	100	100	100
EBITDA Margin (%)	- -	-9,217.03	-14,728.71	-4,828.25	-3,058.15	-3,785.02	-525.16	-410.43	-831.03	-1,250.47
Operating Margin (%)	- -	-9,406.94	-15,130.28	-4,966.94	-3,136.39	-3,922.35	-545.27	-423.28	-849.21	-1,273.14
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	- -	-9,406.31	-15,060.88	-4,905.54	-3,038	-3,806.16	-556.8	-368.52	-636.12	-1,656.34
Profit Margin (%)	- -	-9,406.31	-15,060.88	-4,905.54	-3,038	-3,806.16	-556.8	-368.52	-636.12	-1,656.34
Net Income to Common Margin (%)	- -	-10,962.78	-16,222.08	-4,905.54	-3,038	-3,806.16	-556.8	-368.52	-636.12	-1,656.34
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	14.14	14.2	7.16	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Total Debt	- -	- -	- -	- -	- -	26	66	65	64	62
ST Debt	- -	- -	- -	- -	- -	1	2	2	2	9
LT Debt	- -	- -	- -	- -	- -	25	64	63	62	53
Total Debt/EBITDA	- -	-0.01	- -	- -	- -	-0.35	-0.84	-0.68	-0.51	-0.5
Net Debt/EBITDA	4.58	1.23	1.25	0.61	0.8	0.55	1.7	0.54	1.03	0.79
Total Debt/EBIT	- -	-0.01	- -	- -	- -	-0.33	-0.8	-0.66	-0.5	-0.49
Net Debt/EBIT	4.5	1.2	1.22	0.59	0.78	0.53	1.63	0.52	1	0.78
EBITDA to Interest Expense	- -	- -	- -	- -	-62,692	-1,041.93	-44.23	-24.67	-29.91	-24.23
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	-64,076	-1,217.46	-46.09	-24.99	-30.21	-24.29
EBIT to Interest Expense	- -	- -	- -	- -	-64,296	-1,079.74	-45.92	-25.45	-30.57	-24.67
Interest Expense	- -	- -	- -	- -	- -	- -	2	4	4	5
Common Equity/Total Assets	-38.53	-122.64	-110.85	-197.79	-203.73	-195.32	-176.77	-253.41	-228.32	-429.78
Long-Term Debt/Equity (%)	- -	0.61	0.07	0.01	0.03	31.12	71.21	74.14	48.15	318.59
Long-Term Debt/Capital (%)	- -	0.71	-0.05	- -	-0.01	-9.23	-20.75	-15.86	-12.43	-8.03
Long-Term Debt/Total Assets (%)	- -	0.47	0.06	0.01	0.02	16.43	30.24	34.54	25.15	31.56
Total Debt/Equity (%)	- -	1	0.27	0.08	0.04	32.73	73.12	76.5	49.77	372.55
Total Debt/Capital (%)	- -	1.18	-0.22	-0.03	-0.01	-9.71	-21.31	-16.36	-12.85	-9.4
Total Debt/Total Assets (%)	- -	0.78	0.24	0.07	0.03	17.28	31.05	35.64	26	36.91
Net Debt to Equity	-100.25	-105.46	-72.69	-49.3	-63.48	-52.34	-148.46	-61.07	-99.28	-589.98
Net Debt/Capital (%)	2,911.91	508.05	36.71	17.19	18.66	13.43	27.73	10.61	19.15	12.28
EBITDA	-13	-29	-47	-53	-63	-75	-79	-96	-124	-124
EBITDA-CapEx	-13	-30	-49	-54	-64	-88	-83	-98	-125	-125
Operating Income (Loss)	-13	-30	-48	-55	-64	-78	-82	-99	-126	-126

Liquidity (USD)

API Chat

	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Cash Ratio	48.24	4.51	8.74	5.8	5.1	3.89	6.08	4.14	6.57	3.8
Current Ratio	48.36	4.58	8.94	5.89	5.21	4.87	6.24	4.33	6.87	3.95
Quick Ratio	48.24	4.51	8.83	5.8	5.1	4.74	6.16	4.23	6.63	3.8
CFO/Avg Current Liab	- -	-5	-4.63	-4.07	-2.52	-2.8	-2.2	-3.31	-3.95	-3.25
Common Equity/Total Assets	-38.53	-122.64	-110.85	-197.79	-203.73	-195.32	-176.77	-253.41	-228.32	-429.78
Long-Term Debt/Equity (%)	- -	0.61	0.07	0.01	0.03	31.12	71.21	74.14	48.15	318.59
Long-Term Debt/Capital (%)	- -	0.71	-0.05	- -	-0.01	-9.23	-20.75	-15.86	-12.43	-8.03
Long-Term Debt/Total Assets (%)	- -	0.47	0.06	0.01	0.02	16.43	30.24	34.54	25.15	31.56
Total Debt/Equity (%)	- -	1	0.27	0.08	0.04	32.73	73.12	76.5	49.77	372.55
Total Debt/Capital (%)	- -	1.18	-0.22	-0.03	-0.01	-9.71	-21.31	-16.36	-12.85	-9.4
Total Debt/Total Assets (%)	- -	0.78	0.24	0.07	0.03	17.28	31.05	35.64	26	36.91
CFO/Total Liabilities	-955.23	-240.35	-378.1	-339.78	-143.06	-85.11	-46.75	-101.87	-105.41	-72.41
CFO/CapEx	-59.55	-19.58	-17.46	-54.48	-29.13	-4.77	-17.2	-79.95	-99.17	-403.33
Altman's Z-Score	-0.1	-3.18	6.36	7.14	-0.02	-1.35	-0.39	-3.27	-3.72	-6.79

Working Capital (USD)

API Chat

	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Accounts Receivable Turnover	- -	- -	0.73	2.54	- -	0.2	1.51	6,710.86	- -	- -
Days Sales Outstanding	- -	- -	499.14	143.71	- -	1,841.57	241.92	0.05	- -	- -
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Market Capitalization	- -	- -	154	247	182	278	500	204	45	221
- Cash & Cash Equivalents	60	36	59	32	50	41	174	92	167	140
+ Preferred Equity and Hybrid Capital	82	82	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	- -	26	66	65	64	62
Enterprise Value	22	46	71	175	82	212	392	139	-93	143
Total Capital	58	29	-101	-155	-217	-267	-311	-398	-495	-661
Total Debt/Capital (%)	- -	1.18	-0.22	-0.03	-0.01	-9.71	-21.31	-16.36	-12.85	-9.4
Total Debt / EV	- -	0.01	- -	- -	- -	0.12	0.17	0.47	-0.68	0.43
EV/Sales	- -	146.51	224.03	159.14	40.12	107.18	25.96	5.9	- -	14.41
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	154	247	182	278	500	204	45	221
Diluted Enterprise Value	22	46	96	215	132	262	392	177	-59	143
EV per Share	87.33	187.61	55.93	68.96	25.19	52.82	85.1	22.18	- -	5.06
TTM Sales	- -	- -	- -	1	2	2	15	23	15	10
TTM EBITDA	-13	-29	-47	-53	-63	-75	-79	-96	-124	-124
TTM Operating Income	-13	-30	-48	-55	-64	-78	-82	-99	-126	-126
TTM Cash Flow to Firm	-12	-23	-41	-45	-40	-60	-56	-96	-119	-105
TTM Free Cash Flow to Firm	-12	-22	-38	-44	-39	-48	-52	-94	-118	-104

Multiples (USD)

API Chat

	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Price/Free Cash Flow	- -	- -	-4.04	-5.63	-4.67	-5.84	-9.25	-2.07	-0.37	-2.02
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	22	46	71	175	82	212	392	139	-93	143
Low Price	- -	- -	81.6	63	54	44.5	42.6	32.3	3.02	2.09
EV/Sales	- -	146.51	224.03	159.14	40.12	107.18	25.96	5.9	- -	14.41
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	-3.31	-7.08	-5.58	-3.93	-4.98	-4.52	-1.32	-0.61
Price/Earnings High	- -	- -	-5.31	-11.47	-7.27	-6.36	-8.58	-11.19	-5.14	-1.39
Price/Earnings Low	- -	- -	-2.01	-2.96	-2.83	-2.37	-2.33	-2.33	-0.4	-0.36
Price/Book Value	- -	- -	-1.53	-1.59	-0.84	-0.95	-1.33	-0.44	-0.08	-0.31
Price/Book Value Average	- -	- -	-1.68	-2.46	-1.6	-1.01	-1.11	-0.84	-0.22	-0.14
Price/Book Value High	- -	- -	-2.7	-3.99	-2.08	-1.64	-1.91	-2.09	-0.87	-0.32
Price/Book Value Low	- -	- -	-1.02	-1.03	-0.81	-0.61	-0.52	-0.44	-0.07	-0.08
Price/Tangible Book Value	- -	- -	1.92	3.78	2.31	3.51	5.52	2.39	0.36	13.24
Price/Tangible Book Value Average	- -	- -	2.11	5.85	4.42	3.74	4.62	4.6	0.98	6.06
Price/Tangible Book Value High	- -	- -	3.39	9.48	5.76	6.06	7.96	11.37	3.81	13.69
Price/Tangible Book Value Low	- -	- -	1.29	2.45	2.24	2.26	2.17	2.37	0.3	3.55
Price/Sales	- -	- -	487.03	224.53	88.73	140.23	33.11	8.68	3.05	22.21
Price/Sales Average	- -	- -	536.2	347.29	169.39	149.48	27.7	16.67	8.39	10.16
Price/Sales High	- -	- -	861.11	562.48	220.79	242.1	47.75	41.24	32.68	22.95
Price/Sales Low	- -	- -	326.82	145.38	86.02	90.31	13	8.6	2.56	5.96
Price/Cash Flow	- -	- -	-3.81	-5.53	-4.51	-4.61	-8.71	-2.05	-0.37	-2.01
Price/Cash Flow Average	- -	- -	-4.19	-8.55	-8.61	-4.92	-7.29	-3.93	-1.02	-0.92
Price/Cash Flow High	- -	- -	-6.73	-13.85	-11.23	-7.96	-12.56	-9.73	-3.95	-2.08
Price/Cash Flow Low	- -	- -	-2.56	-3.58	-4.37	-2.97	-3.42	-2.03	-0.31	-0.54
Price/Free Cash Flow Average	- -	- -	-4.45	-8.71	-8.92	-6.22	-7.74	-3.98	-1.03	-0.92
Price/Free Cash Flow High	- -	- -	-7.14	-14.1	-11.63	-10.08	-13.34	-9.85	-3.99	-2.08
Price/Free Cash Flow Low	- -	- -	-2.71	-3.65	-4.53	-3.76	-3.63	-2.05	-0.31	-0.54
EV/Sales Average	- -	146.51	352.07	318.08	145.07	141.64	20.56	15.52	1.41	2.37
EV/Sales High	- -	146.51	676.99	533.28	196.47	234.27	40.61	40.09	25.7	15.15
EV/Sales Low	- -	146.51	142.7	116.18	61.7	82.47	5.86	7.45	- -	- -
EV/EBITDA Average	-1.64	-1.59	-2.39	-6.59	-4.74	-3.74	-3.92	-3.78	-0.17	-0.19
EV/EBITDA High	-1.64	-1.59	-4.6	-11.04	-6.42	-6.19	-7.73	-9.77	-3.09	-1.21
EV/EBITDA Low	-1.64	-1.59	-0.97	-2.41	-2.02	-2.18	-1.12	-1.81	0.53	0.15
EV/EBIT Average	-1.61	-1.56	-2.33	-6.4	-4.63	-3.61	-3.77	-3.67	-0.17	-0.19
EV/EBIT High	-1.61	-1.56	-4.47	-10.74	-6.26	-5.97	-7.45	-9.47	-3.03	-1.19
EV/EBIT Low	-1.61	-1.56	-0.94	-2.34	-1.97	-2.1	-1.07	-1.76	0.52	0.14
Last Price	- -	- -	121.6	97.3	55.7	69.1	108.5	32.6	3.59	7.79
High Price	- -	- -	215	243.75	138.6	119.3	156.5	154.9	38.5	8.05
Enterprise Value Average	22	46	112	350	297	281	310	365	21	24
Enterprise Value High	22	46	215	587	403	464	613	942	382	151
Enterprise Value Low	22	46	45	128	126	163	88	175	-66	-18

	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Shares Outstanding	2	2	2	3	3	4	6	6	20	26
Diluted Weighted Avg Shares	- -	- -	1	3	3	4	5	6	13	28
Basic Weighted Avg Shares	- -	- -	1	3	3	4	5	6	13	28
Revenue per Share	- -	1.28	0.25	0.43	0.63	0.49	3.28	3.76	1.18	0.35
EBITDA per Share	-53.23	-118.03	-36.77	-20.92	-19.2	-18.65	-17.21	-15.42	-9.79	-4.39
Operating Income per Share	-54.27	-120.46	-37.78	-21.52	-19.69	-19.33	-17.87	-15.9	-10	-4.47
Basic EPS, GAAP	-63.19	-140.38	-40.5	-21.26	-19.07	-18.76	-18.25	-13.84	-7.49	-5.81
Basic EPS from Cont Ops	-54.25	-120.45	-37.6	-21.26	-19.07	-18.76	-18.25	-13.84	-7.49	-5.81
Diluted EPS, GAAP	-63.19	-140.38	-40.5	-21.26	-19.07	-18.76	-18.25	-13.84	-7.49	-5.81
Diluted EPS from Cont Ops	-54.25	-120.45	-37.6	-21.26	-19.07	-18.76	-18.25	-13.84	-7.49	-5.81
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-48.35	-93.03	-31.93	-17.61	-12.35	-14.98	-12.46	-15.92	-9.74	-3.87
Free Cash Flow per Basic Share	-49.16	-97.78	-33.76	-17.93	-12.77	-18.12	-13.18	-16.12	-9.84	-3.88
Cash & Equivalents per Share	243.96	145.05	65.84	28.36	30.52	22.73	37.78	20.85	16.02	4.93
Book Value per Share	-95.71	-216.16	-79.73	-61.1	-66.61	-72.83	-81.86	-74.13	-44.19	-25.52
Tangible Book Value per Share	-87.95	-193.75	63.48	25.71	24.06	19.69	19.66	13.63	10.11	0.59

Syros Pharmaceuticals, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)